153 related articles for article (PubMed ID: 20921955)
1. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients.
Chan MK; Tsang TM; Harris LW; Guest PC; Holmes E; Bahn S
Mol Psychiatry; 2011 Dec; 16(12):1189-202. PubMed ID: 20921955
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
3. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
4. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.
Lan MJ; McLoughlin GA; Griffin JL; Tsang TM; Huang JT; Yuan P; Manji H; Holmes E; Bahn S
Mol Psychiatry; 2009 Mar; 14(3):269-79. PubMed ID: 18256615
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
6. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.
Torres KC; Souza BR; Miranda DM; Nicolato R; Neves FS; Barros AG; Dutra WO; Gollob KJ; Correa H; Romano-Silva MA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):214-9. PubMed ID: 19059449
[TBL] [Abstract][Full Text] [Related]
7. Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients.
Ding L; Hegde AN
Biol Psychiatry; 2009 Mar; 65(6):541-5. PubMed ID: 19041089
[TBL] [Abstract][Full Text] [Related]
8. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides.
Schwarz E; Prabakaran S; Whitfield P; Major H; Leweke FM; Koethe D; McKenna P; Bahn S
J Proteome Res; 2008 Oct; 7(10):4266-77. PubMed ID: 18778095
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
[TBL] [Abstract][Full Text] [Related]
11. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.
Sakai T; Oshima A; Nozaki Y; Ida I; Haga C; Akiyama H; Nakazato Y; Mikuni M
Neuropathology; 2008 Apr; 28(2):143-50. PubMed ID: 18069969
[TBL] [Abstract][Full Text] [Related]
12. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.
Martins-de-Souza D; Maccarrone G; Wobrock T; Zerr I; Gormanns P; Reckow S; Falkai P; Schmitt A; Turck CW
J Psychiatr Res; 2010 Dec; 44(16):1176-89. PubMed ID: 20471030
[TBL] [Abstract][Full Text] [Related]
13. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder.
Toro CT; Hallak JE; Dunham JS; Deakin JF
Neurosci Lett; 2006 Sep; 404(3):276-81. PubMed ID: 16842914
[TBL] [Abstract][Full Text] [Related]
14. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study.
Frey BN; Stanley JA; Nery FG; Monkul ES; Nicoletti MA; Chen HH; Hatch JP; Caetano SC; Ortiz O; Kapczinski F; Soares JC
Bipolar Disord; 2007 Jun; 9 Suppl 1():119-27. PubMed ID: 17543030
[TBL] [Abstract][Full Text] [Related]
15. A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania.
Frey BN; Folgierini M; Nicoletti M; Machado-Vieira R; Stanley JA; Soares JC; Kapczinski F
Hum Psychopharmacol; 2005 Mar; 20(2):133-9. PubMed ID: 15648094
[TBL] [Abstract][Full Text] [Related]
16. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study.
Laifenfeld D; Karry R; Klein E; Ben-Shachar D
Biol Psychiatry; 2005 Apr; 57(7):716-25. PubMed ID: 15820228
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia.
Pongrac JL; Middleton FA; Peng L; Lewis DA; Levitt P; Mirnics K
Biol Psychiatry; 2004 Dec; 56(12):943-50. PubMed ID: 15601604
[TBL] [Abstract][Full Text] [Related]
18. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.
Huang JT; Wang L; Prabakaran S; Wengenroth M; Lockstone HE; Koethe D; Gerth CW; Gross S; Schreiber D; Lilley K; Wayland M; Oxley D; Leweke FM; Bahn S
Mol Psychiatry; 2008 Dec; 13(12):1118-28. PubMed ID: 17938634
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Hidaka S; Asada T
Neurosci Res; 2004 Sep; 50(1):77-84. PubMed ID: 15288501
[TBL] [Abstract][Full Text] [Related]
20. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics.
Marx CE; Stevens RD; Shampine LJ; Uzunova V; Trost WT; Butterfield MI; Massing MW; Hamer RM; Morrow AL; Lieberman JA
Neuropsychopharmacology; 2006 Jun; 31(6):1249-63. PubMed ID: 16319920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]